Tweet
Two Centers of excellence will be established in the region, as US-based Bioheart has planed, in order to provide its cell therapy procedures to patients with congestive heart failure (CHF) and peripheral arterial disease (PAD).
Dr Karl Groth, chairman and CEO, Bioheart, said ‘We feel that the Middle East region is a splendid second site for [...]










Recent Comments